期刊文献+

Ⅳ期结直肠癌外科治疗方式的选择 被引量:1

The stage Ⅳ Colorectal cancer surgery treatment options
暂未订购
导出
摘要 目的评价不同手术切除方式对Ⅳ期结直肠癌预后的作用和意义。方法回顾性分析167例Ⅳ期结直肠癌的临床资料,将这167例患者分为两组:95例根治性切除组与72例姑息性切除或仅行造瘘术组。比较两组患者的手术并发症发生率、手术死亡率以及长期生存率。结果根治性切除组手术并发症发生率为15.2%,姑息性切除或仅行造瘘术组手术并发症发生率为27.9%(P<0.05);根治性切除组手术死亡率为3.1%,姑息性切除或仅行造瘘术组死亡率为5.5%(P>0.05);根治性切除的患者术后1、3、5年生存率为85.7%、63.2%、38.4%,姑息性切除术后1、3、5年的生存率分别为67.5%、41.3%、8.6%,仅行造瘘的患者术后1、3、5年的生存率分别为45.3%、0%、0%。结论对于Ⅳ期结直肠癌施行积极的根治性切除手术可改善患者的预后。 Objective To investigate the value of different surgery therapy for the stage Ⅳ colorectal cancer. Methods A retrospective analysis of 167 cases of colorectal cancer Ⅳphase of the clinical data of the 167 cases were divided into two groups : 95 cases of radical resection group and 72 cases of palliative resection or only line of PEG group. Comparing the two groups of patients with surgical complication rate, surgical mortality and long-term survival. Results Group results of the radical resection surgery complication rate was 15.2%, or only palliative resection surgery bank Group PEG complication rate was 27. 9% (P 〈 0. 05 ) ; radical resection surgery group mortality rate was 3.1%, palliative Resection or only line of PEG group mortality rate was 5.5% (P 〉 0. 05) ; radical resection of the patients after 1,3, 5-year survival rate was 85.7%, 63.2%, 38.4%, after palliative resection 1,3, 5-year surwival rates were 67.5%, 41.3%, 8.6% , the only line of ostomy patients after 1, 3, 5-year survival rates were 45.3% ,0% ,0%. Conclution Stage Ⅳ coloreetal cancer patients adopt an active radieal surgery can improve the prognosis of patients.
出处 《中国实用医药》 2009年第21期20-21,共2页 China Practical Medicine
关键词 结直肠癌 根治性切除 预后 Coloreetal cancer Radical resection Prognosis
  • 相关文献

参考文献10

  • 1Hermanek P.Multiviszerale Resection beim kolorektalen Karzinom-Erfahrungen der SGKRK-Studie.Langenbecks Arch Chir,1992,377(2):95-100.
  • 2Rowe VL,Frost DB,Huang S.Extended resection for locally advanced colorectal carcinoma.Ann Surg Oncol,1997,4(2):131-136.
  • 3Hermanek P,Mansmann U,Staimmer D,et al.The German experience:The surgeon as a prognostic factor in colon and rectal surgery.Surg Clin North Am,2000,9(1):33-49.
  • 4Montesani C,Ribotta G,De Milito R,et al.Extend resection in the treatment of colorectal cancer.Int J Colorectal Dis,1991,6(2):161-164.
  • 5Hunter JA,Ryan JA,Schultz P.En bloc resection of colon cancer adherent to other organs.Am J Surg,1987,145(1):67-71.
  • 6Nicoli N,Cassaril A,Mangiante G,et al.Surgical treatmrnt for liver metastases from colorectal carcinoma:results of 228 patients.Hepatogastroenterology,2004,51(12):1810-1814.
  • 7王平.结直肠癌肝转移的外科治疗现状[J].中华肝胆外科杂志,2003,9(1):59-60. 被引量:7
  • 8P.M.Schlag,T.Benhidjeb,B.Kilpert.Prinzipien der kurativen Lebermetastasenresekion.Deutsche Medizin,2000,17(1):2-9.
  • 9Harmon KE,Ryan JA,Biehl TR,et al.Benefits and safety of hepatic resection for colorectal metastases.Am Surg,1999,177(5):402-404.
  • 10Adam R,Pascal G,Azoulay D,et al.Liver resection for colorectal metastases:the third hepatectomy.Ann Surg,2003,238(9):871-883.

二级参考文献3

  • 1Kenzo Yasui,Takashi Hirai,Tomoyuki Kato,Takeshi Morimoto,Akihito Torii,Katsuhiko Uesaka,Yasuhiro Kodera,Yoshitaka Yamamura,Tuyoshi Kito. Major anatomical hepatic resection with regional lymph node dissection for liver metastases from colorectal cancer[J] 1995,Journal of Hepato - Biliary - Pancreatic Surgery(2):103~107
  • 2Johannes Scheele M.D.,Richard Stang M.D.,Annelore Altendorf-Hofmann M.D.,Martin Paul M.D.. Resection of colorectal liver metastases[J] 1995,World Journal of Surgery(1):59~71
  • 3Ib Krogh Pedersen M.D.,Flemming Burcharth M.D.,Ole Roikj?r M.D.,Helge Baden M.D.. Resection of liver metastases from colorectal cancer[J] 1994,Diseases of the Colon &amp; Rectum(11):1078~1082

共引文献6

同被引文献23

  • 1Siegel R, Naishadham D, Jemal A. Cancer Statistics,2013 [ J]. CA Cancer J Clin ,2013,63 ( 1 ) : 11-30.
  • 2Jemal A, Siegel R, Ward E, et al, Cancer statistics(2009) [J]. CA Cancer J Clin,2009,59(4) :225-249.
  • 3Mella J, Biffin A, Radcliffe AG, et al. Population-based audit of coloreetal cancer management in two UK health regions. Coloreetal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit [ J ]. Br J Surg, 1997,84 ( 12 ) : 1731-1736.
  • 4Choi HJ, Shin JY. Colorectal cancer with multiple metastases: is palliative surgery needed? [J]. J Korean Soc Coloproctol,2011, 27 (5) :226-230.
  • 5Costi R, Mazzeo A, Di Mauro D, et al. Palliative resection of colorectal cancer: does it prolong survival? [ J]. Ann Surg Onco1,2007,14 ( 9 ) :2567-2576.
  • 6Anwar S, Peter MB, Dent J, et al. Palliative excisional surgery for primary colorectal cancer in patients with incurable metastatic disease. Is there a survival benefit? A systematic review [J]. Colorectal Dis,2012,14(8) :920-930.
  • 7Costi R, Di Manro D, Veronesi L, et al. Elective palliative resec- tion of incurable stage IV eoloreetal cancer: who really benefits from it? [J]. Surg Today,2011,41(2) :222-229.
  • 8Park JH, Kim TY, Lee KH, et al. The beneficial effect of pallia- tive resection in metastatic colorectal cancer [ J ]. Br J Cancer, 2013,108(7) :1425-1431.
  • 9Siegel R, Dcsantis C, Jemal A. Clolrectal cancer statistics, 2014 [J]. CA Cancer J Chn,2014,64(2) :104-117.
  • 10Siegel R, Ma J, Zou Z, et al. Cancer statistics,2014[J]. CA Cancer J Clin,2014,64( 1 ) :9-29.

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部